Integration of molecular modelling and in vitro studies to inhibit LexA proteolysis
Zachariah P. Schuurs(Translational Research Institute), Neha S. Gandhi(Queensland University of Technology)
Cited by 4
Related Papers
Synthetic Heparan Sulfate Mimetic Pixatimod (PG545) Potently Inhibits SARS-CoV-2 by Disrupting the Spike–ACE2 Interaction
|ACS Central Science|2022|112
Pixatimod (PG545), a clinical-stage heparan sulfate mimetic, is a potent inhibitor of the SARS-CoV-2 virus
|Unknown|2020|16
Synthetic Heparan Sulfate Mimetic Pixatimod (PG545) Potently Inhibits SARS-CoV-2 By Disrupting The Spike-ACE2 interaction
|bioRxiv (Cold Spring Harbor Laboratory)|2020|12
Amphiphilic Heparinoids as Potent Antiviral Agents against SARS-CoV-2
|Journal of Medicinal Chemistry|2024|7